REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

SunWay Biotech Co., Ltd. (Taiwan, China)

Main Activities: Medicinal and Botanical Manufacturing
Full name: SunWay Biotech Co., Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

SunWay Biotech Co., Ltd. researches, designs, manufactures and develops NTU 568 red sorghum strain and NTU 101 lactic acid bacteria strain. The company was founded in 2007 and is headquartered in Taipei, Taiwan.

Headquarters
No.139, Xing Ai Rd., Neihu District
Taipei City; Taipei City;

Contact Details: Purchase the SunWay Biotech Co., Ltd. report to view the information.

Website: http://www.sunway.cc

Basic Information
Total Employees:
Purchase the SunWay Biotech Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the SunWay Biotech Co., Ltd. report to view the information.
Financial Auditors:
Purchase the SunWay Biotech Co., Ltd. report to view the information.
Incorporation Date:
September 10, 2007
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
4.71%
Purchase this report to view the information.
4.69%
Purchase this report to view the information.
2.59%
Purchase this report to view the information.
1.09%
Purchase this report to view the information.
0.29%
Subsidiaries
Sunway Group Holding Limited
100%
保瑞聯邦(股)公司
100%
宸潤行銷股份有限公司
51%
Company Performance
Financial values in the chart are available after SunWay Biotech Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
226.76%▲
Total operating revenue
226.6%▲
Operating profit (EBIT)
60.55%▲
EBITDA
91.63%▲
Net Profit (Loss) for the Period
81.86%▲
Total assets
340.74%▲
Total equity
551.65%▲
Operating Profit Margin (ROS)
-18.02%▼
Net Profit Margin
-11.78%▼
Return on Equity (ROE)
-5.75%▼
Quick Ratio
-1.43%▼
Cash Ratio
-2.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo